Psychological intervention reduces disability and depression in adolescents with fibromyalgia
Posted in

Psychological intervention reduces disability and depression in adolescents with fibromyalgia

A recent trial shows cognitive-behavioral therapy (CBT) reduces functional disability and depressive symptoms in adolescents with juvenile fibromyalgia. The psychological intervention was found to be safe and effective, and proved to be superior to disease…

Psychological intervention reduces disability and depression in adolescents with fibromyalgia Read More
Adolescents with fibromyalgia who are physically active report lower levels of pain and disability
Posted in

Adolescents with fibromyalgia who are physically active report lower levels of pain and disability

Adolescents with fibromyalgia who are physically active report lower levels of pain and disability, according to findings of a multicenter study published in The Journal of Pain, published by the American Pain Society. Led by…

Adolescents with fibromyalgia who are physically active report lower levels of pain and disability Read More
Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It
Posted in

Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It

“Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.” In 2017, tocilizumab (Actemra), a biologic drug that inhibits interleukin-6 (IL-6), was FDA-approved for giant cell arteritis — an inflammation of…

Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It Read More
error: Content is protected !!